{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:19:42Z","timestamp":1770905982021,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12886-016-0348-4","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:09:01Z","timestamp":1475280541000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction"],"prefix":"10.1186","volume":"16","author":[{"given":"Dordi","family":"Austeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tora Sund","family":"Morken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine","family":"Bolme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turid","family":"Follestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidar","family":"Halsteinli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"key":"348_CR1","volume":"8","author":"SD Solomon","year":"2014","unstructured":"Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014;8, CD005139.","journal-title":"Cochrane Database Syst Rev"},{"key":"348_CR2","volume":"5","author":"T Braithwaite","year":"2014","unstructured":"Braithwaite T, Nanji AA, Lindsley K, Greenberg PB. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion. Cochrane Database Syst Rev. 2014;5, CD007325.","journal-title":"Cochrane Database Syst Rev"},{"key":"348_CR3","volume":"10","author":"G Virgili","year":"2014","unstructured":"Virgili G, Parravano M, Menchini F, Evans JR. Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev. 2014;10, CD007419.","journal-title":"Cochrane Database Syst Rev"},{"key":"348_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432\u201344.","journal-title":"N Engl J Med"},{"key":"348_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419\u201331.","journal-title":"N Engl J Med"},{"key":"348_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1136\/bjo.87.3.312","volume":"87","author":"CG Owen","year":"2003","unstructured":"Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol. 2003;87:312\u20137.","journal-title":"Br J Ophthalmol"},{"key":"348_CR7","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajo.2014.06.012","volume":"158","author":"JB Jonas","year":"2014","unstructured":"Jonas JB, Bourne RRA, White RA, Flaxman SR, Keeffe J, Leasher J, et al. Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis. Am J Ophthalmol. 2014;158:808\u201315.","journal-title":"Am J Ophthalmol"},{"key":"348_CR8","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","volume":"119","author":"DF Martin","year":"2012","unstructured":"The CATT Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology. 2012;119:1388\u201398.","journal-title":"Ophthalmology"},{"key":"348_CR9","doi-asserted-by":"publisher","unstructured":"Berg K, Hadzalic E, Gjertsen I, Forsaa V, Berger LH, Kinge B, et al. Ranibizumab or bevacizumab for neovascular age-related macular degeneration according to the lucentis compared to avastin study treat-and-extend protocol: two-year results. Ophthalmology. 2015 Oct 15. doi: \n                    10.1016\/j.ophtha.2015.09.018\n                    \n                  . [Epub ahead of print]","DOI":"10.1016\/j.ophtha.2015.09.018"},{"key":"348_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/bjophthalmol-2011-301378","volume":"96","author":"S Resnikoff","year":"2012","unstructured":"Resnikoff S, Felch W, Gauthier TM, Spivey B. The number of ophthalmologist in practice and training worldwide: a growing gap despite more than 200 000 practitioners. Br J Ophthalmol. 2012;96:783\u20137.","journal-title":"Br J Ophthalmol"},{"key":"348_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/eye.2014.153","volume":"28","author":"P Simcock","year":"2014","unstructured":"Simcock P, Kingett B, Mann N, Reddy V, Park J. A safety audit of the first 10 000 intravitreal ranibizumab injections performed by nurse practitioners. Eye. 2014;28:1161\u20134.","journal-title":"Eye"},{"key":"348_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/eye.2014.69","volume":"28","author":"J DaCosta","year":"2014","unstructured":"DaCosta J, Hamilton R, Nago J, Mapani A, Kennedy E, Luckett T, et al. Implementation of a nurse-delivered intravitreal injection service. Eye. 2014;28:734\u201340.","journal-title":"Eye"},{"key":"348_CR13","first-page":"755","volume":"8","author":"MM Michelotti","year":"2014","unstructured":"Michelotti MM, Abugreen S, Kelly SP, Morarji J, Myerscough D, Boddie T, et al. Transformational change: nurses substituting for ophthalmologists for intravitreal injections\u2014a quality-improvement report. Clin Ophthalmol. 2014;8:755\u201361.","journal-title":"Clin Ophthalmol"},{"key":"348_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.12968\/ijop.2013.4.2.68","volume":"4","author":"D Varma","year":"2013","unstructured":"Varma D, Lunt D, Johnson P, Stanley S. A novel approach to expanding the role of nurses to deliver intravitreal injections for patients with age-related macular degeneration. Int J Ophthalmic Pract. 2013;4:68\u201374.","journal-title":"Int J Ophthalmic Pract"},{"key":"348_CR15","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","author":"Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group","year":"1999","unstructured":"Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Arch Ophthalmol. 1999;117:1329\u201345.","journal-title":"Arch Ophthalmol"},{"key":"348_CR16","unstructured":"The Norwegian Knowledge Centre for the Health Services. \n                    www.kunnskapssenteret.no\n                    \n                  . Accessed 20 Aug 2014."},{"key":"348_CR17","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1001\/jama.2012.87802","volume":"308","author":"G Piaggio","year":"2012","unstructured":"Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG. Reporting of noninferiority and equivalence randomized trials. Extension of the CONSORT 2010 Statement. JAMA. 2012;308:2594\u2013604.","journal-title":"JAMA"},{"key":"348_CR18","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"DF Martin","year":"2011","unstructured":"The CATT Research Group, Martin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med. 2011;364:1897\u2013908.","journal-title":"N Engl J Med"},{"key":"348_CR19","first-page":"479","volume":"49","author":"KG Csaky","year":"2008","unstructured":"Csaky KG, Richman EA, Ferris FL. Report from the NEI\/FDA ophthalmic clinical trial design and endpoints symposium. IOVS. 2008;49:479\u201389.","journal-title":"IOVS"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-016-0348-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-016-0348-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T20:10:59Z","timestamp":1487707859000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-016-0348-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1186\/s12886-016-0348-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,1]]},"article-number":"169"}}